Evidence map›Paper›PMID 31126688›Full record

ArticleJournal of pediatric surgery2020

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee.

Christopher B Weldon, Arin L Madenci, Gregory M Tiao, Stephen P Dunn, Max R Langham, Eugene D McGahren, Sarangarajan Ranganathan, Dolores H López-Terrada, Milton J Finegold, Marcio H Malogolowkin and 5 more

Abstract read
In one paragraph

Article in Journal of pediatric surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. The Role of IR in Pediatric Liver Cancer.Seminars in interventional radiology · 2025
    Review
  5. Hepatoblastoma.Nature reviews. Disease primers · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Christopher B WeldonDepartments of Surgery & Pediatric Oncology, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA. Electronic address: Christopher.Weldon@childrens.harvard.edu.
Arin L MadenciDepartments of Surgery & Pediatric Oncology, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA. Electronic address: Arin.Madenci@childrens.harvard.edu.
Gregory M TiaoDepartment of Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Stephen P DunnDepartment of Surgery, Nemours Children's Health System, Wilmington, DE.
Max R LanghamDivision of Pediatric Surgery, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN.
Eugene D McGahrenDepartment of Pediatric Surgery, University of Virginia Health System, Charlottesville, VA.
Sarangarajan RanganathanDivision of Pediatric Pathology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
Dolores H López-TerradaDepartment of Pathology and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Milton J FinegoldDepartment of Pathology and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Marcio H MalogolowkinDivision of Hematology/Oncology, Department of Pediatrics, University of California Davis Comprehensive Cancer Center, Sacramento, CA.
Jin PiaoDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA; Children's Oncology Group, Monrovia, CA.
Li HuangChildren's Oncology Group, Monrovia, CA.
Mark D KrailoDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA; Children's Oncology Group, Monrovia, CA.
Rebecka L MeyersDivision of Pediatric Surgery, Primary Children's Hospital, University of Utah, Salt Lake City, UT.
Howard M KatzensteinDivision of Hematology/Oncology, Department of Pediatrics, Nemours Children's Specialty Care/Wolfson Children's Hospital, Jacksonville, FL.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
QUALITY ASSURANCE REVIEW CENTER (QARC)U10CA029511 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, THOMAS J. · 1985 to 2013
$23.4M
NCI NIH HHS U10 CA029511NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

backgroundThe histopathological assessment of pediatric liver tumors at presentation is critical to establish a diagnosis, guide treatment, and collect appropriate research samples. The purpose of this study was to evaluate complications associated with different approaches to liver biopsy for newly diagnosed hepatoblastoma.

methodsChildren with hepatoblastoma were enrolled on Children's Oncology Group study AHEP0731 (September 2009-March 2012). This analysis evaluated the study cohort of initially unresectable patients who therefore underwent a biopsy procedure at diagnosis. The primary endpoint was clinically significant postbiopsy hemorrhage, defined as requiring red blood cell transfusion.

resultsWe identified 121 children who underwent open (n = 76, 63%), laparoscopic (n = 17, 14%), or percutaneous (n = 28, 23%) liver biopsies. All biopsy procedures yielded adequate tissue for diagnosis. Postbiopsy hemorrhage requiring transfusion occurred after 26% (n = 31) of biopsies. Need for blood product transfusion most frequently occurred following open (n = 27/76, 36%) and laparoscopic (n = 4/17, 24%) biopsies, compared with percutaneous (n = 0/28, 0%) biopsies (p < 0.01).

conclusionsPretreatment biopsy of pediatric liver tumors via a percutaneous approach yielded the lowest frequency of clinically significant hemorrhage requiring transfusion, without evidence of sacrificing diagnostic accuracy. LEVEL OF EVIDENCE: Level I.

Indexed as

AdolescentBiopsyChildChild, PreschoolFemaleHepatoblastomaHumansInfantLaparoscopyLiver NeoplasmsMaleNeoplasm StagingPostoperative HemorrhageBiopsyHepatoblastomaIntraoperative complicationsMinimally invasive surgical proceduresOncologyPediatrics

Identifiers

PMID31126688
PMCPMC6842675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.